Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

Cardiovascular Events Clinical Trial

Official title:

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01395550
• Other study ID #: NIS-CZA-XXX-2011/1
• Status: Completed
• Phase: N/A
• First received: June 14, 2011
• Last updated: August 29, 2011
• Start date: January 2010
• Est. completion date: July 2010

Study information

• Verified date: August 2011
• Source: AstraZeneca
• Contact: n/a
• Is FDA regulated: No
• Health authority: South Africa: None
• Study type: Observational

Clinical Trial Summary

AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 88
• Est. completion date: July 2010
• Est. primary completion date: July 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• All patients who has experienced cardiovascular events

Exclusion Criteria:

• Patients with no cardiovascular events.

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• Cardiovascular Events

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
AstraZeneca